Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens

There are currently three oral medications approved for the treatment of multiple sclerosis (MS). Two of these medications, Fingolimod, and Teriflunomide, are considered to be anti-inflammatory agents, while dimethyl fumarate (DMF) is thought to trigger a robust antioxidant response, protecting vuln...

Descripción completa

Detalles Bibliográficos
Autores principales: Rumah, Kareem R., Vartanian, Timothy K., Fischetti, Vincent A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263136/
https://www.ncbi.nlm.nih.gov/pubmed/28180112
http://dx.doi.org/10.3389/fcimb.2017.00011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263136/
https://www.ncbi.nlm.nih.gov/pubmed/28180112
http://dx.doi.org/10.3389/fcimb.2017.00011

Ejemplares similares